Jefferies Upgrades Aegerion Pharma To Buy, Sees Positively Skewed Risk/Reward

By: via Benzinga
In a report published Tuesday, Jefferies analyst Eun K. Yang upgraded the rating on Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.